Significant Ownership of Enavate Sciences GP, LLC
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Enavate Sciences GP, LLC focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/ James P. Boylan - By James P. Boylan, Manager
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Enavate Sciences GP, LLC with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Enavate Sciences GP, LLC
Significant Ownership of Enavate Sciences GP, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Common Stock, par value $0.0001 per share | 7.3% | $87,013,952 | 3,919,159 | Enavate Sciences GP, LLC | 09 Oct 2025 | ||
| SION | SIONNA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 5.6% | $29,835,481 | 2,478,030 | Enavate Sciences GP, LLC | 10 Feb 2025 | ||
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock, $0.0001 par value per share | 4.8% | $10,955,517 | -$2,773,593 | 2,495,562 | -20% | Enavate Sciences GP, LLC | 09 Mar 2026 |
| IMNM | IMMUNOME, INC. | Common Stock, par value $0.0001 per share | 4.3% | $73,483,864 | 4,768,583 | Enavate Sciences GP, LLC | 18 Dec 2025 |
Schedules 13D/G Reported by Enavate Sciences GP, LLC:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.